Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel

被引：0
|
作者：
Garcia, Annie [1 ]
Reuther, Jacquelyn [2 ]
Voicu, Horatiu [2 ]
Mohila, Carrie [3 ]
Adesina, Adekunle [2 ]
Schady, Deborah [3 ]
Wang, Wei-Lien Billy [4 ]
Lazar, Alexander [4 ]
Lopez-Terrada, Dolores [2 ]
Lin, Frank [2 ]
Venkatramani, Rajkumar [2 ]
Plon, Sharon [2 ]
Parsons, Williams [2 ]
Fisher, Kevin [2 ]
Roy, Angshumoy [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
39
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [21] Real-World Experience of NTRK Fusion-Positive Thyroid Cancer
    Park, Jong Chul
    Ashok, Arya
    Liu, Chienying
    Kang, Hyunseok
    JCO PRECISION ONCOLOGY, 2022, 6
  • [22] Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers
    Willis, Connor
    Au, Trang
    Hejazi, Andre
    Griswold, Cassia
    Schabath, Matthew B.
    Thompson, Jonathan
    Malhotra, Jyoti
    Federman, Noah
    Ko, Gilbert
    Appukkuttan, Sreevalsa
    Warnock, Neil
    Kong, Sheldon X.
    Hocum, Brian
    Brixner, Diana
    Stenehjem, David
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (07): : 672 - 683
  • [23] NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
    Marczyk, Vicente R.
    Fazeli, Sasan
    Dadu, Ramona
    Busaidy, Naifa L.
    Iyer, Priyanka
    Hu, Mimi I.
    Sherman, Steven I.
    Hamidi, Sarah
    Hosseini, Sayed Mohsen
    Williams, Michelle D.
    Ahmed, Salmaan
    Routbort, Mark J.
    Luthra, Raja
    Roy-Chowdhuri, Sinchita
    San Lucas, Francis Anthony
    Patel, Keyur P.
    Hong, David S.
    Zafereo, Mark
    Wang, Jennifer R.
    Maniakas, Anastasios
    Waguespack, Steven G.
    Cabanillas, Maria E.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [24] Entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis
    Garrido-Laguna, I.
    Lonardi, S.
    Bazhenova, L.
    Peeters, M.
    Longo, F.
    Sigal, D.
    Conkling, P.
    Duffaud, F.
    Klingbiel, D.
    Bordogna, W.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S370 - S371
  • [25] Efficacy and Safety of Larotrectinib in Pediatric Patients with NTRK Fusion-Positive Primary Central Nervous System (CNS) Tumors
    Goto, Hiroaki
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [26] Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Drilon, Alexander E.
    Hellmann, Matthew David
    Wang, Lu
    Cho, Eun Jung
    Ladanyi, Marc
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC
    Cho, B. C.
    Chiu, C-H.
    Massarelli, E.
    Chawla, S. P.
    Buchschacher, G. L., Jr.
    Goto, K.
    Kim, S-W.
    Overbeck, T. R.
    Loong, H. H. F.
    Chee, C. E.
    Garrido, P.
    Heinzmann, S.
    Pitcher, B.
    John, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S82 - S83
  • [28] Uterin spindle cell mesenchymal neoplazm, NTRK fusion-positive uterine sarcoma
    Konuk, B.
    Topal, C. S.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S264 - S264
  • [29] NTRK Fusion-Positive Congenital Spinal Glioblastoma treated with Carboplatin, Etoposide, and Larotrectinib
    Vallis, Graham
    PEDIATRICS, 2021, 147 (03)
  • [30] Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma
    Simmons, Christine
    Deyell, Rebecca J.
    MacNeill, Andrea J.
    Vera-Badillo, Francisco E.
    Smrke, Alannah
    Abdul Razak, Albiruni R.
    Banerji, Shantanu
    McLeod, Deanna
    Noujaim, Jonathan
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (09) : 1691 - 1704
12345